This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Self-Management » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Metformin Induces Long-Term Weight Loss in Teens

Posted: Friday, July 07, 2006

Metformin can induce long-term weight loss in obese, non-diabetic adolescents, and could possibly be useful in a regimen to help achieve weight loss in adolescents, who may have developed type 2 diabetes type due to overweight.

Sanofi's Acomplia (rimonabant) Weight Loss Drug Gets EU Approval

Posted: Friday, July 07, 2006

The European Commission has approved 20-mg tablets of rimonabant for use as an adjunct to diet and exercise in the treatment of obese or overweight patients with associated cardiometabolic risk factors such as type 2 diabetes or dyslipidemia.

Statins Prevent Cataracts, Also?

Posted: Friday, June 30, 2006

People taking statins to lower their cholesterol may reap another reward. A new study shows the drugs may also reduce the risk for the most common type of cataract by 60%.

AHA Dietary and Lifestyle Recommendations Revised June, 2006

Posted: Friday, June 30, 2006

The 2006 AHA diet and lifestyle recommendations include guidelines for a healthy diet; healthy weight; cholesterol, BP, and fasting blood sugar control; use of supplements; physical activity; and avoidance of tobacco.

New Drug Galvus Lowers A1c 2.8%

Posted: Friday, June 23, 2006

Galvus, a new once-daily oral treatment option for type 2 diabetes, lowers A1c 2.8% and demonstrates impressive efficacy, especially in patients with poor glycemic control, as well as weight loss benefits in obese patients.

Many Doctors Aren't Treating Diabetes Aggressively Enough

Posted: Thursday, June 15, 2006

FOUR studies find that this is true for patients with high blood pressure, and elevated blood sugar.

Once-Weekly BYETTA (Exenatide) LAR Improves Glucose Control in Patients with Type 2 Diabetes

Posted: Thursday, June 15, 2006

Reduces A1c by 2 points and average weight lose of 8 pounds in 15 weeks.

Ten Thousand Patients Using Levemir Insulin Show Improvements in BG Without Weight Gain

Posted: Thursday, June 15, 2006

Levemir reduced mean A1C levels by 0.54 percent for type 1 and 0.89 percent for type 2 diabetes patients.

Alternative to Carb Counting

Posted: Thursday, June 15, 2006

Study shows an innovative mealtime insulin dosing algorithm provides alternative to carb counting for Type 2’s.

Patients Fail To Grasp Importance of Cholesterol Numbers

Posted: Friday, June 09, 2006

A better way to drive home the message is to concentrate on cardiovascular risk-adjusted age-a formula that homes in on the grim fact that, as an example, a 42-year-old man with elevated Framingham Heart Score has the heart of a 70-year-old man.